HMMJ:CA:TSX-Global X Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 10.25

Change

0.00 (0.00)%

Market Cap

CAD 0.08B

Volume

8.09K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.56 (+1.43%)

CAD 2.72B
ZWU:CA BMO Covered Call Utilities ETF

-0.06 (-0.58%)

CAD 1.78B
TXF:CA First Asset Tech Giants Covere..

+0.21 (+0.97%)

CAD 0.68B
HTA:CA Tech Achievers Growth & Income..

+0.20 (+1.06%)

CAD 0.62B
XHC:CA iShares Global Healthcare (CAD..

-0.40 (-0.54%)

CAD 0.61B
XIT:CA iShares S&P/TSX Capped Informa..

+0.63 (+1.24%)

CAD 0.61B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.02 (-0.10%)

CAD 0.43B
CWW:CA iShares Global Water Common Cl..

-0.54 (-0.96%)

CAD 0.34B
HHL:CA Harvest Healthcare Leaders Inc..

-0.01 (-0.12%)

CAD 0.33B
ZUH:CA BMO Equal Weight US Health Car..

-0.20 (-0.29%)

CAD 0.29B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.33% 87% B+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.33% 87% B+ 69% C-
Trailing 12 Months  
Capital Gain 19.05% 77% C+ 77% C+
Dividend Return 2.21% 64% D 38% F
Total Return 21.26% 80% B- 78% C+
Trailing 5 Years  
Capital Gain -72.64% 9% A- 6% D-
Dividend Return 5.44% 45% F 23% F
Total Return -67.20% 9% A- 7% C-
Average Annual (5 Year Horizon)  
Capital Gain -7.96% 6% D- 8% B-
Dividend Return -5.58% 6% D- 10% F
Total Return 2.38% 66% D+ 62% D
Risk Return Profile  
Volatility (Standard Deviation) 41.99% 9% A- 21% F
Risk Adjusted Return -13.30% 9% A- 24% F
Market Capitalization 0.08B 51% F 34% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.